ACMPR Dried Cannabis – 1/11/17Market Reports
Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available dried cannabis flowers and milled blends to understand how these prices change over time, and to highlight offerings with the best value.
The data for this summary was taken January 11th 2017 (Delta 9 figures January 10 current). Publicly available information on producer websites and newsletters was logged for all available dried cannabis flower and blends in the ACMPR. THC and CBD content and non-compassionate price were logged for each strain and, in the cases where ranges of cannabinoids were given, midpoint averages were used. For the producers offering volume discounts, we’ve used the cost for the smallest size available. In cases where the same strains were offered by two different providers, and for strains that were available in whole flower and blended form, data was logged for each instance.
All flower and blended dried cannabis offerings were categorized according to cannabinoid content. Offerings with ratios of 1.4+ THC:CBD were considered THC offerings. Those with 1.4-0.3 THC:CBD were considered 1:1 offerings, while the remainder (<0.3 THC:CBD) were considered CBD offerings.
There were 161 blends and flowers available from the 21 Licensed Producers in the ACMPR, up from 155 offerings from December 16 2016. The average number of selections per producer is 7 — no change from last month. Most producers carried at least 5 THC offerings, some doubled this average (Hydropothecary and Whistler) while others had one (Aurora, Mettrum) or none (Tweed). Five percent of strains had significant amounts of CBD and negligible amounts of CBD, offered from a third of the producers (Aphria, Aurora, Bedrocan, CanniMed, Canntrust, Hydropothecary, MedReleaf and Tweed). On average, each producer carried a 1:1 strain with significant amounts of THC and CBD, while some had as high as 3 choices (AB Cann, Canna Farms, Hydropothecary, MariCann and Tweed).
Hydropothecary has several new offerings included in the scan this week. Notably, they offer a decarboxylated cannabis product that has been milled and prepared for oral consumption via the provided capsules.
Of the 161 currently available offerings, 123 of them (76%) contained significant amounts of THC to CBD. As noted above, 8 of the 161 (5.0%) were found to have significant amounts of CBD with negligible amounts of CBD. The remaining 19% were found to be 1:1 offerings with comparable cannabinoid content.
Looking at price with respect to cannabinoid content, the average prices for 100mg of THC rose slightly from $5.42 to $5.72. Per producer, prices ranged from $3.45 to $9.50 per 100 mg, with Redecan, Aurora and Bedrocan showing lowest averages for 100mg of THC.
This month, 24% of THC offerings (30 of the 123 offerings) claimed above 20% THC. The average THC content for THC offerings was 17%.
Prices are typically higher for CBD strains: the average price of 100mg of CBD was $7.44 this month, down from $8.14 last month. Average prices per producer ranged from $4.21 to $10.34, with Aurora and CanniMed being the lowest cost providers.
Cannabinoid prices from 1:1 offerings have also increased. For 100mg of THC/CBD from a 1:1 strain, the average price is $5.73, up from $5.47 last month. Producer averages ranged from $3.35 to $10.20, with Redecan showing the lowest average prices.
This summary tracks cannabinoid content and price from around the ACMPR. Much of the data presented here is shown as a summarized producer average comprised of several offerings. For strain specific information, as well as information on each producer, check out Lift and read the reviews in the review section.